PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30828537-6	2019	Furthermore, the released beta-lapachone is capable of producing ROS under the catalysis of nicotinamide adenine dinucleotide (NAD)(P)H:quinone oxidoreductase-1 (NQO1), which induces the self-amplifiable disassembly of the micelles and drug release to consume adenosine triphosphate (ATP) and downregulate P-glycoprotein (P-gp), eventually overcoming MDR.	NAD	92-125	ATP binding cassette subfamily B member 1	Homo sapiens	306-320	
30828537-6	2019	Furthermore, the released beta-lapachone is capable of producing ROS under the catalysis of nicotinamide adenine dinucleotide (NAD)(P)H:quinone oxidoreductase-1 (NQO1), which induces the self-amplifiable disassembly of the micelles and drug release to consume adenosine triphosphate (ATP) and downregulate P-glycoprotein (P-gp), eventually overcoming MDR.	NAD	92-125	ATP binding cassette subfamily B member 1	Homo sapiens	322-326	
25964294-7	2015	Combining Pgp inhibitors with APO866 led to increased intracellular APO866 levels, compounded NAD(+) and ATP shortage, and induced DeltaPsi(m) dissipation.	NAD	94-100	ATP binding cassette subfamily B member 1	Homo sapiens	10-13